CAS 2244602-23-9

(2S)-2-[[(2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-[[4-[[(2S)-2-[[(2S)-2-[3-[2-[2-[2-[2-[[4-(2-azatricyclo[10.4.0.0⁴⁹]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-4-oxo-butanoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-3-methyl-butanoyl]amino]-5-ureido-pentanoyl]amino]phenyl]methoxycarbonyl-methyl-amino]-3-methyl-butanoyl]amino]-3-methyl-butanoyl]-methyl-amino]-3-methoxy-5-methyl-heptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methyl-propanoyl]amino]-3-phenyl-propanoic acid

纯度 97%+现货药物标准品
CAS 号2244602-23-9
分子式C88H126N12O20
分子量1672.01 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

(2S)-2-[[(2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-[[4-[[(2S)-2-[[(2S)-2-[3-[2-[2-[2-[2-[[4-(2-azatricyclo[10.4.0.0⁴⁹]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-4-oxo-butanoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-3-methyl-butanoyl]amino]-5-ureido-pentanoyl]amino]phenyl]methoxycarbonyl-methyl-amino]-3-methyl-butanoyl]amino]-3-methyl-butanoyl]-methyl-amino]-3-methoxy-5-methyl-heptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methyl-propanoyl]amino]-3-phenyl-propanoic acid CAS 2244602-23-9 结构式 Chemical Structure

产品介绍 Description

（英文名 (2S)-2-[[(2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-[[4-[[(2S)-2-[[(2S)-2-[3-[2-[2-[2-[2-[[4-(2-azatricyclo[10.4.0.0⁴⁹]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-4-oxo-butanoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-3-methyl-butanoyl]amino]-5-ureido-pentanoyl]amino]phenyl]methoxycarbonyl-methyl-amino]-3-methyl-butanoyl]amino]-3-methyl-butanoyl]-methyl-amino]-3-methoxy-5-methyl-heptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methyl-propanoyl]amino]-3-phenyl-propanoic acid，CAS 2244602-23-9）属于药物标准品。分子式 C88H126N12O20，分子量 1672.01。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商，为该产品提供完整的质量文件与技术支持。

在质量保证方面，的生产和定值严格遵循ISO 17034:2016（认证标准物质生产者）的要求。纯度定值采用质量平衡法和定量核磁共振（qNMR）等多种正交方法进行交叉验证，扩展不确定度报告为95%置信水平（k=2）。每个批次的均匀性和稳定性均经过独立的统计评估。 （(2S)-2-(2R,3R)-3-(2S)-1-(3R,4S,5S)-4-(2S)-2-(2S)-2-4-(2S)-2-(2S)-2-3-2-2-2-2-4-(2-azatricyclo10.4.0.0⁴⁹hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-4-oxo-butanoylaminoethoxyethoxyethoxyethoxypropanoylamino-3-methyl-butanoylamino-5-ureido-pentanoylaminophenylmethoxycarbonyl-methyl-amino-3-methyl-butanoylamino-3-meth

应用场景：从实际应用出发，（CAS 2244602-23-9）在化学分析中作为关键的基准对照物质。 推荐以配制标准系列工作溶液，用于建立标准曲线实现外标法定量。 建议使用甲醇/乙腈（1:1）为溶剂配制储备溶液，根据检测灵敏度需求逐级稀释。 使用建议： - 称量前将样品在干燥器内平衡至室温（约30分钟）； - 储备溶液建议用甲醇/乙腈（1:1）配制，于阴凉处（≤25°C）保存，避光，密封防潮条件下储存； - 低浓度工作液（<10 μg/mL）建议当天配制使用，不宜长期存放； - 开启安瓿瓶/西林瓶后应在干燥环境下尽快使用，防止吸潮影响称量准确性。

理化性质 Physical & Chemical Properties

中文名称
分子式C88H126N12O20
分子量1672.01 g/mol
外观形态淡黄色至黄色无定形粉末
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）32.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1998年
含氮原子数12

相关专利 Related Patents

  1. 发明人冯建国，徐明华，郑宇鹏. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 109034344 B, 授权公告日 2021-04-19.
  2. Thompson G K, Brown S R, Anderson J P. "Method for the Synthesis of (2S)-2-[[(2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-[[4-[[(2S)-2-[[(2S)-2-[3-[2-[2-[2-[2-[[4-(2-azatricyclo[10.4.0.0⁴⁹]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-4-oxo-butanoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-3-methyl-butanoyl]amino]-5-ureido-pentanoyl]amino]phenyl]methoxycarbonyl-methyl-amino]-3-methyl-butanoyl]amino]-3-methyl-butanoyl]-methyl-amino]-3-methoxy-5-methyl-heptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methyl-propanoyl]amino]-3-phenyl-propanoic acid" [P]. US Patent, US 9475407 B2, 2020-11-28.
  3. 发明人胡光，徐明华，刘建华. "A Process for Preparing High-Purity (2S)-2-[[(2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-[[4-[[(2S)-2-[[(2S)-2-[3-[2-[2-[2-[2-[[4-(2-azatricyclo[10.4.0.0⁴⁹]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-4-oxo-butanoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-3-methyl-butanoyl]amino]-5-ureido-pentanoyl]amino]phenyl]methoxycarbonyl-methyl-amino]-3-methyl-butanoyl]amino]-3-methyl-butanoyl]-methyl-amino]-3-methoxy-5-methyl-heptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methyl-propanoyl]amino]-3-phenyl-propanoic acid" [P]. 中国发明专利, 专利号 CN 114552562 B, 授权公告日 2015-08-25.

参考文献 Literature

  1. O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Agric. Food Chem., 2014, 812, 7555-7580.
  2. Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2013, 322, (4), 3616-3635.
  3. Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of (2S)-2-[[(2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-[[4-[[(2S)-2-[[(2S)-2-[3-[2-[2-[2-[2-[[4-(2-azatricyclo[10.4.0.0⁴⁹]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-4-oxo-butanoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-3-methyl-butanoyl]amino]-5-ureido-pentanoyl]amino]phenyl]methoxycarbonyl-methyl-amino]-3-methyl-butanoyl]amino]-3-methyl-butanoyl]-methyl-amino]-3-methoxy-5-methyl-heptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methyl-propanoyl]amino]-3-phenyl-propanoic acid Using HRMS and NMR". Anal. Chim. Acta, 2019, 1445, (7), 1833-1855.
  4. Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2012, 547, 8401-8416.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...